This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,853.55 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of November 7, 2024.
This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
The contract does not have a set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's significant role in supplying essential medications and medical commodities to various federal healthcare programs, including those serving military personnel, veterans, and other government beneficiaries.
Generated 2/27/25, 12:29 PM